Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Breast Cancer Research

Fig. 4

From: Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer

Fig. 4

Relationship between median lymphocyte density, cellular composition, pathological complete response (pCR) and receptor status. Bar plots illustrating the relationship between pathological complete response, oestrogen receptor (ER) status, human epidermal growth factor receptor 2 (HER2) status, cellular composition and median lymphocyte density. Plots are sorted by increasing level of median lymphocyte density. For illustration, median lymphocyte density has been rescaled to positive values

Back to article page